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In earlier studies we found that treatment with interferon-g (IFN-g) produced an 8- to 11-fold increase in choline acetyltrans-
ferase (ChAT) in cultured cells taken from Embryonic Day 16 (E16) septal nuclei with adjacent basal forebrain (SN/BF).
Since younger cultures responded even more profoundly to IFN treatment, we have tested the possibility that the action
of IFN (or its intermediate; see below) is to prompt the cholinergic differentiation of neuronal precursors. SN/BF cultures
of various ages were labeled with a retrovirus engineered to express b-galactosidase (Lac-Z), and ChAT-positive descendants
of the retrovirally labeled precursors were counted. IFN-g treatment of cultures caused as much as an 8.8-fold increase in
the proportion of ChAT-positive cells present in Lac-Z-positive clones, suggesting that IFN promoted cholinergic differentia-
tion in precursor populations. By contrast, bFGF increased clone size but did not change the proportion of ChAT-positive
cells. NGF affected neither. Only ameboid microglia present in the cultures responded to IFN with characteristic nuclear
translocation of the signal transducing molecule p91, suggesting that a microglial-derived molecule may mediate the action
of IFN. Consistent with this hypothesis, conditioned media from cultures of enriched, activated microglia also increased
ChAT activity in a dose-dependent fashion. Conditioned media from an unstimulated macrophage/monocyte cell line
(RAW 264.7) also proved extremely ef®cacious in raising ChAT activity. In addition, conditioned media from both activated
microglia and RAW 264.7 cells increased the proportion of ChAT-positive cells in retrovirally labeled clones to the same
extent as IFN itself, suggesting the possibility that they contain the molecule(s) that mediates the action of IFN. Preliminary
characterization of this molecule suggests that it is a very stable and large protein. Together these data suggest that a
molecule promoting cholinergic differentiation is produced by activated microglia and other macrophage-like cells. The
identity of this molecule and its precise role in normal development await its further puri®cation. q 1996 Academic Press, Inc.
INTRODUCTION 1994). In cultures of SN/BF taken from rats at Embryonic
Day 16 (E16), IFN-g increases ChAT activity as much as
Growth and differentiation factors known to regulate he- 11-fold, a rise that is accompanied by a rise in mRNA for
matopoiesis (the immune cytokines) also play a role in the the enzyme (Jonakait et al., 1994). The effect is age-depen-
developing nervous system (see Mehler and Kessler, 1994; dent, E14 cultures responding more robustly than E18 cul-
Patterson and Nawa, 1993; Merrill and Jonakait, 1995; Jona- tures. While merely doubling the number of neurons in the
kait, 1996 for reviews). In previous studies designed to in- cultures, IFN increases the number of cholinergic neurons
vestigate immune system factors that regulate the develop- 8- to 9-fold.
ment of cholinergic neurons of the septal nuclei and adja- Since IFN is not mitogenic and because the effect of IFN
cent basal forebrain (SN/BF), we found that interferon-g is so clearly age-dependent, one mode by which IFN might
(IFN-g) exerts a profound effect on the expression of choline act to increase cholinergic neuron number is by prompting
acetyltransferase (ChAT), the enzyme responsible for the dividing, undifferentiated precursors to generate postmi-
biosynthesis of acetylcholine and the de®ning phenotypic totic cholinergic neurons. The increased number of undif-
ferentiated precursors present at earlier ages would, then,characteristic of the cholinergic neuron (Jonakait et al.,
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(approximately 2 1 105 cells/cm2). The initial plating medium con-account for the enhanced responsiveness of younger cul-
tains SCM. Medium is exchanged after 3 days. At Days 6 and 10,tures. The current study provides data that are consistent
half the medium is exchanged for fresh medium.with this hypothesis by using retroviral markers genetically
After 11 days in culture, ¯asks are vigorously shaken on an or-engineered to express the enzyme Escherichia coli b-galac-
bital shaker at 400 rpm for 10 min, and the medium (containingtosidase (lac-Z; Price et al., 1987; Sanes, 1989; Luskin et al.,
dislodged oligodendroglia and microglia) is pelleted (1000 RPM 1
1988). These nonreplicating viruses integrate into the DNA 5 min), resuspended in SCM, and plated (unless otherwise indi-
of proliferating precursors, allowing for identi®cation of cated) at a density of 6 1 105 cells/ml into uncoated ¯asks. Micro-
their progeny. If IFN (or its intermediate; see below) acts glia are allowed to settle onto the ¯asks for 3 hr at 377C. The ¯asks
in accord with our hypothesis, then cultures infected with are then gently rapped to dislodge oligodendroglia. The medium
containing oligodendroglia is discarded and is replaced with oneretrovirus and treated with IFN should reveal retrovirally
containing half serum-containing medium (as above) and half N2labeled clones with a greater proportion of cholinergic neu-
medium. After an additional 24 hr, the medium is changed to 100%rons than control cultures. The action of IFN on cholinergic
N2 medium with or without 50 U/ml murine recombinant IFNgdifferentiation was compared to that of basic ®broblast
(Genzyme). Control conditioned medium (CT-CM) and IFN-CMgrowth factor (bFGF) and nerve growth factor (NGF), other
are collected the next day. In the cultures, the ratio of CM to controlimportant regulators of cholinergic development (Martinez
media is 2:1. Hence ``full-strength'' of CM means that it constitutes
et al., 1987; Anderson et al., 1988; Knusel et al., 1990; Ku- 67% of the ®nal culture media.
shima et al., 1992; Yokoyama et al., 1994) and hence possi- Purity of these cultures was assessed by staining with DiI-labeled
ble intermediates. low-density lipoprotein (DiI-Ac-LDL) using minor modi®cations
Since ameboid microglia present in the cultures are the of the manufacturer's instructions (Biomedical Technologies, Inc.,
data sheet). Greater than 97% of cells in the cultures were labeledonly cells that respond to IFN with nuclear translocation
by an overnight incubation with 1 mg/ml DiI-Ac-LDL, suggestingof p91 [a biochemical indicator of IFN responsiveness (Shuai
their microglial nature.et al., 1992); Jonakait et al., 1994], and since IFN is a well-
Preparation of RAW 264.7 cells. Stocks of RAW 264.7 cells areknown activator of microglia (Arenzana-Seisdedos et al.,
maintained in SCM and, in this medium, double every 16±24 hr.1985; Colton et al., 1992; Chao et al., 1992; Steiniger and
RAW 264.7 cell stocks are passaged each week. When used forVan der Meide, 1988), a microglial product was considered
generation of conditioned medium, they are plated at a density of
a likely mediator of IFN's action. This hypothesis has been 3 1 106 cells/25-cm2 ¯ask. On the second day of culture, medium
strengthened by the recent ®nding of Kenigsberg and Maz- is shifted from one containing 100% SCM to one containing 50%
zoni (1995) that inclusion of even unactivated microglia to SCM, 50% N2. On the third day, medium is again changed to a
E17 cultures of medial septal area increases ChAT activity ¯ask containing 100% N2. The following day, conditioned medium
is harvested.in these cultures. The current study pursues this hypothesis
Retrovirus labeling. SN/BF cultures were prepared from em-further, ®nding that conditioned media from activated pri-
bryos of various ages. Cells were plated into poly-lysine-coated Lab-mary microglial cultures as well as that from a monocyte/
Tek (Nunc) slides at a density of 3.5 1 105 cells/well. Final serummacrophage cell line mimic the effects of IFN itself both
concentration was 1.5%. Each individual Lab-Tek slide containsin raising ChAT activity and in facilitating cholinergic dif-
four chambers, each 180 1 106 mm2 in area. After 24 hr, retrovirusferentiation of precursors.
was added. The retrovirus, BAG (Luskin et al., 1993), provided at
a concentration of 1.5 1 105 particles/ml, was diluted 1:25 for a
®nal concentration of 6000 particles/ml. If individual cells are able
MATERIALS AND METHODS to migrate as far as 250 mm in any direction (Price et al., 1987),
their possible area of migration describes a circle with an area of
approx. 200,000 mm2. Since even the most densely labeled cultureCulture Methods
(the E15 control) had a density of retrovirally labeled clones of one
Septal nuclei/basal forebrain. Unless otherwise indicated, cul- clone per 4.9 1 106 mm2 (Table 1), it is unlikely that this titer of
tures of SN/BF are taken from rat embryos at E16. Cells are gently retrovirus resulted in mixing of clones. The numbers of clones
triturated in serum-free medium (Opti-Mem / N2 supplement, labeled in each well at E15 is described in Table 1.
``N2 medium''; Gibco) using a ®re-polished Pasteur pipet. Cells are Four hours after the addition of retrovirus to the cultures, the
further diluted with serum-containing medium (SCM) and plated medium was removed and fresh medium containing test solutions
at a density of 1.5±2 1 105 cells/cm2 into poly-lysine-coated (0.2 was added.
mg/ml) 35-mm tissue culture dishes containing 1 ml N2 medium
or other media to be tested. SCM for the cultures contains D-MEM/ ChAT Assay
F12 medium (1:1), penicillin (25 U/ml), streptomycin (25 mg/ml),
Cultures were assayed for ChAT activity using the method ofD-glucose (0.6%), and 10% heat-inactivated fetal calf serum. Final
Fonnum (1975) as modi®ed by Martinez et al. (1987) and used byserum concentration in the cultures is 2.5%.
us previously (Shadiack et al., 1993; Jonakait et al., 1994). TotalMicroglial cultures. Enriched microglia are prepared from neo-
protein in the cultures was assayed using the Bio-Rad protein assay.natal rat cortex using minor modi®cations of published differential
plating techniques (Giulian and Baker, 1986; McCarthy and de
Histochemistry and ImmunohistochemistryVellis, 1980). Sterilely dissected tissue is minced and then gently
triturated with a ®re-polished Pasteur pipet and plated into poly- LacZ. Cultures were ®xed with phosphate-buffered 2% para-
formaldehyde and 0.4% glutaraldehyde for 5 min in the cold. Tolysine-coated 25-cm2 ¯asks at a density of one cortex per two ¯asks
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TABLE 1 RESULTS
Retroviral Labeling of Cells Plated at E15 and Subjected to Four
Separate Treatments (See Fig. 1 and Table 2) IFN Treatment Results in the Cholinergic
Differentiation of Undifferentiated PrecursorsNo. Clones/well Clone density
SN/BF cultures of identical densities were establishedControl 37 { 2.1 1 clone/4.9 1 106 mm2
from embryos at E14, E15, and E17. After 24 hr, all culturesIFN-g 18 { 3.8 1 clone/11.6 1 106 mm2
were treated with retrovirus and half of the cultures werebFGF 26 { 3.7 1 clone/7.5 1 106 mm2
NGF 27 { 4.7 1 clone/8.2 1 106 mm2 treated with IFN-g (50 U/ml). They were then allowed to
survive for another 5 days before being ®xed and prepared
Note. Each measurement re¯ects the mean{ SEM of six separate for the simultaneous histochemical demonstration of lacZ
Lab-Tek wells plated at the same time. and immunohistochemical detection of ChAT (Fig. 1). Total
lacZ- and ChAT-positive cells per clone were counted for
each plating age (Table 2).
When clones derived from different aged cultures were
visualize lacZ-positive cells, slides were incubated with b-galactos- compared, the number of lacZ-positive cells per clone was
idase substrate overnight at room temperature (X-Gal, 1 mg/ml in larger in cultures derived from younger embryos, possibly
PBS, containing 0.02% sodium deoxycholate, 0.01% NP-40, 4 mM due to the longer generation time before cessation of cell
potassium ferrocyanide, 4 mM potassium ferricyanide, and 2 mM
division and differentiation. As described by others (Tem-MgCl2).
ple, 1989; Williams et al., 1991), clones comprised mixedChAT. After lacZ staining, cultures were post®xed with 4%
phenotypes, including both neurons and glia (identi®edparaformaldehyde for 5 min, then ChAT immunohistochemical
morphologically), suggesting the existence of (at least) a bi-staining was performed as described by us previously (Martinez et
al., 1985, 1987; Jonakait et al., 1994). Slides were incubated with potential precursor at these ages. IFN treatment doubled
goat polyclonal antibody to ChAT (Chemicon, 1:200) for 48 hr at (E15 and E17) or tripled (E14) the number of cells/clone,
47C, exposed to secondary antibody (rabbit anti-goat, 1:100) for 1 suggesting a modest effect on precursor proliferation or sur-
hr at room temperature, then incubated with goat PAP (1:75). The vival. By contrast, IFN treatment profoundly increased the
PAP complex was visualized with nickel-enhanced DAB (1:20, proportion of ChAT-positive cells present in the clones. E14
Pierce), then coverslipped in sodium bicarbonate/glycerin (1:1). cultures were particularly responsive, increasing by almost
Slides were rinsed twice in PBS between steps. The lacZ/, ChAT/,
ninefold the proportion of ChAT-positive cells in the clonesand double-labeled cells in entire wells were counted.
(from 6.7 { 1.4 to 59.5 { 3.3%, Table 2). Consistent with
our own previous data, older cultures were less responsive
to the effects of IFN; E17 cultures barely tripled their propor-
tion of ChAT-positive cells. This may be due to the factWestern Blotting
that E14 cultures contain a higher number of precursors
Western blots of bFGF were performed by standard methods us- with cholinergic potential than do the E17 cultures, which
ing antibodies against bFGF (Sigma) at a concentration of 1:1000. may have already begun to exhaust their cholinergic precur-
Two milliliters of RAW-CM was concentrated 10-fold using a Cen- sor pool.
tricon 10. The pattern of clonal development was different with
IFN-g than it was with NGF and bFGF (Tables 3 and 4),
suggesting that neither of these is the intermediate mole-
cule involved in the IFN-induced cholinergic differentia-Materials
tion. NGF had no effect on the number of cells/clone (Table
3), the clone size distribution (Table 4), nor the proportionBDNF, NT-3, and NT-4 were gifts from Regeneron Pharmaceuti-
of cholinergic cells present in the clones (Table 3), sug-cals (Tarrytown, NY). GDNF was a gift from Amgen. MDF (muscle-
gesting that NGF acts on something other than precursorderived factor) was a gift from Lorraine Iacovitti, Hahnemann Uni-
versity. NGF and Cardiotrophin I were gifts from Genentech. differentiation and in line with the suggestion of others
FIG. 1. Histochemical and immunohistochemical detection of lacZ and ChAT in E15 SN/BF cultures treated for 5 days with (A) nothing,
(B) IFN-g, (C) bFGF, or (D) NGF. Cholinergic neurons labeled by antibody to ChAT are brown (arrowheads). Cells expressing lacZ retrovirus
are blue (open arrows). Cells containing both the lacZ marker and ChAT are dark gray (solid arrows). After the ®rst 24 hr in culture,
retrovirus was added (see Materials and Methods). Four hours after the addition of retrovirus to the cultures, the medium was removed
and fresh medium was added containing either 50 U/ml mouse recombinant IFN-g (Genzyme) in 2 mM b-mercaptoethanol, 50 ng/ml
bFGF (Sigma), or 50 ng/ml human recombinant NGF (Genentech). While FGF-treated cultures have larger clones, cultures treated with
IFN-g have a larger proportion of cholinergic neurons within single clones (see also Tables 2 and 3).
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TABLE 2
Cholinergic Development of the Progeny of Retrovirally Labeled Precursors in the Presence and Absence of IFNg
Clones Total lacZ/ ChAT/ cells in ChAT/ cells/lacZ/
counted cells Cells/clone all clones cells (%)
Control
E14 138 467 3.4 { 0.3 39 6.7 { 1.4
E15 222 1146 5.2 { 0.4 207 17 { 1.6
E17 76 161 2.1 { 0.2 23 12 { 2.9
IFN-treated
E14 95 885 9.3 { 1.2* 556 59.5 { 3.3*
E15 109 991 9.1 { 0.6* 629 65.7 { 2.4*
E17 104 434 4.2 { 0.3* 164 36.5 { 3.0*
Note. Cultures were established at E14, 15, and 17 (see Fig. 1). A 4-hr period of retroviral labeling occurred 24 hr after plating. IFN-g
(50 U/ml) was added following retroviral labeling and remained in the cultures for an additional 5 days. After staining for the detection
of both lacZ and ChAT (see Fig. 1), retrovirally labeled cells were scored for the presence of ChAT immunoreactivity.
* P  0.0005 compared to the control value of equivalent age in the same category.
that NGF enhances cholinergic neuronal survival following the increased number of cells (and, therefore, the increased
amount of protein) in the FGF-treated cultures meant thatdifferentiation (Hartikka and Hefti, 1988) and/or increases
ChAT protein per cell (Martinez et al., 1987). In two sepa- only IFN showed a dramatic increase when normalized to
protein levels in the culture. The level of NGF-inducedrate experiments, bFGF dramatically increased the number
of cells per clone, but did not substantially affect the propor- ChAT activity was quite low when compared to either of
the other two treatments (also see Table 6).tion of cholinergic cells per clone (Tables 3 and 5). Again,
this suggests that FGF action is other than on cholinergic
differentiation and is in line with the suggestion of others
Precursor Cells Do Not Respond Directly to IFN,that FGF promotes the proliferation and/or survival of a
but Require a Glial Intermediateprecursor population (Gensburger et al., 1987; Cattaneo and
McKay, 1990; Murphy et al., 1990; Mayer et al., 1993; Ves- In previous studies (Jonakait et al., 1994) we found that
ameboid microglia present in the culturesÐand only ameboidcovi et al., 1993; Kitchens et al., 1994; Ghosh and
Greenberg, 1995; Vicario-Abejon et al., 1995). Increased microgliaÐresponded to IFN. Finding a responsive glial cell
suggested that IFN-g did not act directly on neurons (or theirChAT activity seen with FGF treatment, then, could be
construed as the result of an increase in the total number precursors) but instead required a glia-derived intermediate
to effect its action on cholinergic differentiation. In order toof cells rather than an action on precursor determination.
ChAT activity measurements are consistent with these determine whether we could detect a microglial-derived, solu-
ble intermediate, enriched cultures of neonatal cortical mi-observations (Fig. 2). While both IFN and FGF showed a 10-
fold increase in ChAT activity per culture (data not shown), croglia were prepared (see Materials and Methods) in the pres-
TABLE 3
Effect of IFNg, bFGF, or NGF on Cholinergic Differentiation of the Progeny of Retrovirally Labeled E15 Precursors
Clones Total lacZ/ ChAT/ cells ChAT/ cells/lacZ/
counted cells Cells/clonea in all clones cells (%)
Control 222 1146 5.2 { 0.4 207 17.0 { 1.6
IFN-g 109 991 9.1 { 0.6* 629 65.7 { 2.4*
bFGF 159 5307 33.4 { 2.7* 1151 24.1 { 1.6*
NGF 166 733 4.5 { 0.4 147 17.8 { 2.0
Note. SN/BF cultures were established at E15. A 4-hr period of retroviral labeling occurred 24 hr after plating. IFN-g, bFGF, or NGF as
added (concentrations as in Fig. 1) following retroviral labeling; growth factors remained in the cultures for an additional 5 days. After
staining for the detection of both lacZ and ChAT (see Fig. 1), lacZ/ cells were scored for the presence of ChAT immunoreactivity.
a See Table 4 for clone size distributions.
* P  0.005 compared to control value in the same category.
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TABLE 4
Clone Size Distribution from Cultures Plated at E15
No. of cells/clone
1±5 6±10 11 ±15 16±20 21±25 25
Control (222) 67% 22% 6% 2% 2% 1%
IFN-g (109) 24% 40% 11% 9% 3% 3%
bFGF (159) 13% 16% 12% 5% 9% 45%a
NGF (166) 74% 19% 4% 2% 0% 1%
Note. Cultures were prepared as described in Fig. 1 and Table 2. The number of retrovirally labeled cells was counted in each clone,
and then clones were grouped according to the numbers of cells that they contained. The number of clones in each group is expressed as
a percentage of the total number of clones counted. The number of clones counted in each treatment group is in parentheses below the
name of the treatment group. These data represent the compilation of data from six individual Lab-Tek slides all prepared at the same
time. Each Lab-Tek slide contains four chambers, one for each of the four treatment groups.
a The average number of cells per clone in this group was 60 { 4.3.
ence and absence of IFN-g, a known activator of microglia cells does not increase activity further. RAW-CM from 3 1
(Arenzana-Seisdedos et al., 1985; Colton et al., 1992; Chao et 106 cells/ml produces a dose-dependent increase in ChAT
al., 1992; Steiniger and Van der Meide, 1988). Media condi- activity (Fig. 4B).
tioned by these microglia (microglial conditioned media, CM)
were assessed for their ability to promote cholinergic differen-
Actions of the Macrophage-Derived Factor(s) Aretiation of E16 SN/BF cultures. Media conditioned by even
Not Mimicked by Other Known Growth Factorsrelatively high densities of unstimulated microglia did not
increase ChAT activity (data not shown). However, when In order to determine whether the activity derived from
stimulated by IFN, microglia produced media that raised conditioned media is attributable to previously described
ChAT activity substantially. Moreover, increasing the density growth factors, we have compared the activity to that of
of microglia increased the ef®cacy of the CM (Fig. 3). The growth and/or differentiation factors that either have been
effect cannot be due to residual IFN since the IFN concentra- reported to or might be expected to affect ChAT activity.
tion did not increase with increasing microglial density. Dose±response curves have now been constructed for 20
such factors (Table 6). In no case have we found an individ-
A Macrophage Cell Line Also Produces a Highly ual factor that produces the levels of ChAT obtained with
Effective Cholinergic Differentiation Factor RAW-CM.
Since microglia produce a molecule that mimics the ac-
tion of IFN in raising ChAT activity, we tested several mac-
Conditioned Media from both Microglia and RAWrophage/monocyte cell lines to determine whether they,
264.7 Cells Promote Cholinergic Differentiationtoo, might be a source of the cholinergic differentiation
molecule. The mouse monocyte/macrophage cell line RAW In order to investigate the mechanism by which condi-
264.7 (ATCC) produces a soluble cholinergic differentiation tioned media raise ChAT activity, we tested the possibility
factor that is even more ef®cacious than preparations from that these media raise ChAT by the same mechanism as
primary microglia. When added to E16 SN/BF cultures, IFN itself: that is, that they facilitate cholinergic differentia-
RAW 264.7 cell conditioned medium (RAW-CM) routinely tion from undifferentiated precursors.
produces a 15- to 20-fold increase in ChAT activity (Fig. SN/BF cultures were prepared from E15 embryos. Retrovi-
4A). The activity increases with the number of RAW 264.7 rus was added 1 day later. Cultures were then grown for
cells cultured, reaching a plateau at about the same density 5 days with or without RAW-CM, CM from unactivated
(106 cells/ml) as that seen with microglial cells. At very microglia, or IFN-stimulated microglia. Because bFGF is the
high densities, activity begins to fall, possibly because of
only other factor that rivals IFN in raising ChAT activity,
the increased concentration of neurotoxic constituents of
bFGF was also included in this experiment. Clones werethe medium1. The addition of IFN to cultured RAW 264.7
assessed as above for total cell number and for the number
of cholinergic cells/clone (Table 5).1 Activated microglia, at least, are known to produce neurotoxic
As before (Table 3), clones in control and bFGF-treatedmolecules (see, e.g., Giulian et al., 1993a) including glutamate or
cultures contained approximately 20% cholinergic cells.a glutamate-like molecule (Giulian et al., 1993b; Piani et al., 1992),
Clones in cultures treated with unstimulated microglialreactive oxygen radicals (Colton and Gilbert, 1987), and/or nitric
CM contained an equivalent proportion of cholinergic cells.oxide (Chao et al., 1992; Yamamori, 1991; Martin et al., 1993;
Yamamori, 1991). By contrast, CM from activated microglia or from RAW
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TABLE 5
Effect of bFGF and Conditioned Media from Primary Microglia or RAW Cells on Cholinergic Differentiation of the Progeny of
Retrovirally Labeled E15 Precursors
Clones Total lacZ/ ChAT/ cells in ChAT/ cells/lacZ/
counted cells Cells/clone all clones cells (%)
Control 57 245 4.3 { 0.6 44 19.8 { 4.0
bFGF 93 2506 26.9 { 5.1* 680 23.0 { 2.5
Microglia (4) (unstimulated) 13 177 13.6 { 4.0* 77 22.5 { 8.4
Microglia (4) (stimulated) 10 74 7.4 { 1.9 43 54.0 { 11.5*
Microglia (8) (stimulated) 35 244 7.0 { 1.1 121 54.6 { 6.4*
RAW-CM 119 781 6.5 { 0.8 434 59.3 { 3.2*
Note. SN/BF cultures were established at E15. A 4-hr period of retroviral labeling occurred 24 hr after plating. Conditioned media or
bFGF (20 ng/ml) were added as described in the text. Primary microglia were grown at densities of 4 1 105 (4) or 8 1 105 (8) cells/ml.
Cultures remained untouched for an additional 5 days. After staining for the detection of both lacZ and ChAT, lacZ/ cells were scored
for the presence of ChAT immunoreactivity.
* P  0.005 compared to the control value in the same cateogry.
264.7 cells produced clones with a signi®cantly higher per- To test the increasingly unlikely possibility that the ac-
tive factor in RAW-CM is bFGF, Western blots were per-centage of cholinergic cells. These data are consistent with
data derived from IFN-treated cultures (Tables 2 and 3) and formed using various concentrations of authentic bFGF and
concentrated RAW-CM (Fig. 5). Basic FGF was not detectedsuggest the possibility that the IFN-stimulated intermedi-
ate(s) is (are) present in both microglial-CM and RAW-CM. in RAW-CM, suggesting either that it is not elaborated by
these cells or that its concentration is so low (below 1.25While both RAW-CM and microglial-CM are equally ef-
®cacious in promoting cholinergic differentiation (Table 5), ng/ml) that it cannot have accounted for the increase in
ChAT effected by RAW-CM. As seen above (Fig. 2), evenRAW-CM produces a higher fold increase in ChAT activity
than does microglial-CM. This discrepancy may suggest 20 ng/ml of bFGF is not as effective as RAW-CM.
that the factor(s) in RAW-CM not only promotes cholinergic
differentiation, but also increases ChAT per neuron.
Preliminary Characterization of the Factor
Preliminary characterization of the factor from RAW cells
has begun. It is very stable and can be stored in the refrigera-
tor for at least 3 weeks and in the freezer for at least 6
months without substantial loss of activity. Bringing RAW-
CM to 567C for 30 min does not substantially destroy the
activity. However, both trypsin treatment (0.2% for 20 min
at 377C) and boiling for 20 min destroys activity, suggesting
its proteinaceous nature. Lowering the pH to 2.0 for 20 min
or inclusion of 20% ethanol also destroys activity. Activity
can be recovered after 70% ammonium sulfate fraction-
ation, again suggesting that it is a protein. Preliminary size
chromatography (Superose 12) suggests a factor of large mo-
lecular weight, though aggregation has not been ruled out.
DISCUSSION
FIG. 2. Choline acetyltransferase (ChAT) activity in E15 SN/BF
cultures treated with IFN-g, bFGF, NGF, or nothing. IFN-treated These data are consistent with the hypothesis that IFN
cultures express higher levels of speci®c ChAT enzyme activity exerts a differentiating effect on cholinergic precursors
than other cultures. Cultures were plated at a density of 1.25 1
through an intermediate molecule(s) derived from micro-106 cells/dish. Data shown are the means { SE of ChAT activity
glial cells and mimicked by conditioned media from a(n  4 cultures) resulting from treatment with IFN-g, bFGF, or
monocyte/macrophage cell line. Since we have found thatNGF as described in Fig. 1. ChAT activity is expressed as CPM per
IFN treatment of embryonic cortical or hippocampal cellsmicrogram protein. 14C-acetyl Co-A (New England Nuclear) had a
speci®c activity of 56±59 Ci/mM. in culture does not enhance cholinergic expression (Jonakait
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TABLE 6 dramatically altered by low-molecular-weight ``activators,''
Effects of Known Growth and Differentiation Factors on and Mehler et al. (1993) have devised a complicated cocktail
Cholinergic Differentiation in E16 SN/BF Cultures of cytokines that promotes neuronal differentiation in vitro.
Therefore, the possibility that a mixture of molecules is
ChAT activity involved exists.
(fold increase
We were particularly concerned that bFGF was the (orFactor (concentration) over control)
one of the) active molecule involved since, in our hands,
RAW-CM 20.0 { 2.4 (9) bFGF is the only individual growth factor tested that raises
BDNF (10 ng/ml) 4.2 { 0.22 (6) ChAT activity to an extent rivaling that of stimulated mi-
GDNF (10 ng/ml) 3.8 { 0.62 (3) croglia or RAW-CM. However, since (1) neutralizing anti-
NT-4 (25 ng/ml) 2.6 { 0.18 (3) bodies to bFGF do not block the action of IFN (Jonakait et
aFGF (10 ng/ml) 2.5 { 0.26 (3) al., 1994); (2) bFGF has an effect on retrovirally labeled cells
NGF (50 ng/ml) 2.1 { 0.16 (6) that is distinct from effects of IFN, microglial CM, and
GM-CSF (1 ng/ml) 2.1 { 0.68 (3)
RAW-CM; and (3) Western blots reveal that RAW-CM con-Thioredoxin (1 mg/ml) 1.9 { 0.48 (3)
tains negligible amounts of bFGF, it seems unlikely thatTGFb (1 ng/ml) 1.7 { 0.21 (6)
bFGF is the active molecule or even part of a cocktail ofEGF (20 ng/ml) 1.6 { 0.22 (6)
molecules.TNFa (20 U/ml) 1.5 { 0.28 (6)
NT-3 (1 ng/ml) 1.4 { 0.13 (6) These data raise the possibility that beyond the role of
LPS (100 ng/ml) 0.92 { 0.11 (3) phagocytic scavenger (Matsumoto and Ikuta, 1985; Ferrer
RANTES (100 ng/ml) 0.86 { 0.17 (3) et al., 1990), microglia may, during development, play an
VIP (0.1 mM) 0.78 { 0.20 (3) additional role as a source of necessary growth and/or differ-
Cardiotrophin (40 ng/ml) 0.61 { 0.22 (3) entiation factors for developing neurons. Primitive fetal
Midkine (1 ng/ml) 0.39 { 0.10 (3) macrophages (ameboid microglia), the putative precursor of
IGF (20 ng/ml) 0.37 { 0.11 (3)
adult rami®ed (resting) microglia (Perry et al., 1985; GiulianMDF (aFGF / ``activator''; see Du et al., 1994) 0.12 { .01 (3)
and Baker, 1986; Ling and Wong, 1993), are, in fact, presentLIF (500 U/ml) 0.10 { 0.1 (3)
in the lining of the lateral ventricles by E14 (MatsumotoCNTF (10 ng/ml) 0.09 { 0.06 (3)
and Ikuta, 1985). By E16 they are found in clusters (so called
Note. Full dose±response curves were constructed for each factor. ``hot spots'') at the fusion of the corpus callosum overlying
Maximal (or in the cases of RANTES, VIP, Cardiotrophin, IGF, the septum, in the subventricular zone of the lateral ventri-
MDF, LIF, and CNTF, minimal) ChAT activity in treated cultures cle, in the white matter of the cortex, and in the choroid
was compared to that in control (untreated) cultures. ChAT activity
is measured as CPM/mg protein and expressed as a fold increase
over control activity in sister cultures. The number of treated cul-
tures is in parentheses. NGF was added after 3 days in vitro.
et al., 1994), we conclude that this molecule acts only on
precursors with cholinergic potential. Another hypothe-
sisÐthat microglia from different brain regions do not pro-
duce the cholinergic differentiating factor(s) in response to
IFNÐseems less likely. This suggests, then, that 2±3 days
before their differentiation (at least as early as E14), precur-
sor cells in the SN/BF have cholinergic potential and can
be prompted by environmental signals to complete a cholin-
ergic differentiation pathway. An alternative (or conjoint)
hypothesisÐthat the factor speci®cally promotes the sur-
vival of cholinergic precursorsÐcannot be excluded. The
doubling of clone size, in fact, suggests that the factor has,
in addition to its differentiating action, a modest effect on
precursor proliferation and/or survival.
The identity of the differentiating molecule or molecules
FIG. 3. ChAT activity in E16 SN/BF cultures grown for 5 days
is unknown. While we have ruled out several individual with conditioned media from stimulated microglia grown at differ-
growth factors as candidates, there are a host of other factors ent densities. Enriched microglia were cultured as described under
that have not been tested. Moreover, combinations of fac- Materials and Methods and treated for 24 hr with 50 U/ml IFN-g
tors have not been tested. Recent work by Du et al. (1994), prior to the harvest of the conditioned medium. Data are expressed
as the mean { SEM for 3±4 dishes.e.g., suggests that the effects of single growth factors can be
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FIG. 4. Effects of conditioned media from RAW 264.7 cells on ChAT activity in E16 SN/BF cultures (A) treated with conditioned media
from RAW 264.7 cells grown at different densities as described under Materials and Methods or (B) treated with various dilutions of
conditioned media taken from RAW cells grown at a density of 3 1 106 cells/ml. As described under Materials and Methods, CM is
routinely diluted with control media so that at ``full strength,'' the ratio of CM to control media is 2:1. Data are expressed as the mean
{ SEM for 3±4 dishes.
plexus of the lateral ventricle (Perry et al., 1985; Milligan et out. However, any other cytokine that stimulates microglia
(e.g., TNFa, IL-1, IL-3, M-CSF) may play a role in this hypo-al., 1991; Ling and Wong, 1993). They are thus anatomically
poised to play this role in the differentiation of their neigh- thetical developmental cascade. Indeed, there is some evi-
dence that IL-3, M-CSF, and GM-CSF have modest effectsbors within the neuroepithelium.
Must we, however, posit IFN as a necessary stimulus for on cholinergic development in vitro (Kamegai et al.,
1990a,b; Konishi et al., 1993; Burns et al., 1993; Mizuno etembryonic microglia in vivo? While there is limited evi-
dence that astrocytes (Schmidt et al., 1990) and certain neu- al., 1994) and that M-CSF, at least, is present in developing
brain (Burns et al., 1993; Chang et al., 1994). Whether theserons (Eneroth et al., 1992; Bentivoglio et al., 1994; Olsson
et al., 1994) contain IFN, there is no strong evidence for the cytokines exert their effect by stimulating embryonic mi-
croglia and whether microglia, in fact, play a role in cholin-presence of IFN-g in embryonic brain. Maternal sources of
IFN-g (Kruse et al., 1992), of course, should not be ruled ergic differentiation in vivo awaits further study.
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